Chromosomal alterations in cell lines derived from mouse rhabdomyosarcomas induced by crystalline nickel sulfide.
Prior studies have shown a preferential decondensation (or fragmentation) of the heterochromatic long arm of the X chromosome of Chinese hamster ovary cells when treated with carcinogenic crystalline NiS particles (crNiS). In this report, we show that the heterochromatic regions of mouse chromosomes are also more frequently involved in aberrations than euchromatic regions, although the heterochromatin in mouse cells is restricted to centromeric regions. We also present the karyotypic analyses of four cell lines derived from tumors induced by leg muscle injections of crystalline nickel sulfide which have been analyzed to determine whether heterochromatic chromosomal regions are preferentially altered in the transformed genotypes. Common to all cell lines was the presence of minichromosomes, which are acrocentric chromosomes smaller than chromosome 19, normally the smallest chromosome of the mouse karyotype. The minichromosomes were present in a majority of cells of each line although the morphology of this extra chromosome varied significantly among the cell lines. C-banding revealed the presence of centromeric DNA and thus these minichromosomes may be the result of chromosome breaks at or near the centromere. In three of the four lines a marker chromosome could be identified as a rearrangement between two chromosomes. In the fourth cell line a rearranged chromosome was present in only 15% of the cells and was not studied in detail. One of the three major marker chromosomes resulted from a centromeric fusion of chromosome 4 while another appeared to be an interchange involving the centromere of chromosome 2 and possibly the telomeric region of chromosome 17.(ABSTRACT TRUNCATED AT 250 WORDS)
Christie
N T
NT
Institute of Environmental Medicine, New York University Medical Center, NY 10016.
Sen
P
P
Costa
M
M
D000818:Animals; D002503:Centromere / Q000187:drug effects / Q000648:ultrastructure; D002869:Chromosome Aberrations; D004273:DNA, Neoplasm / Q000187:drug effects / Q000235:genetics; D015321:Gene Rearrangement / Q000187:drug effects / Q000235:genetics; D005819:Genetic Markers; D006570:Heterochromatin / Q000187:drug effects / Q000648:ultrastructure; D051379:Mice; D009532:Nickel / Q000633:toxicity*; D012208:Rhabdomyosarcoma / Q000139:chemically induced* / Q000235:genetics; D014407:Tumor Cells, Cultured / Q000648:ultrastructure
D004273:DNA, Neoplasm; D005819:Genetic Markers; D006570:Heterochromatin; C029938:nickel sulfate; D009532:Nickel